Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients

<i>Objectives</i>: To analyze the characteristics and the predictive factors of the use of rituximab and belimumab in daily practice in patients from the inception cohort Registro Español de Lupus (RELES). <i>Material and methods</i>: The study included 518 patients. We consi...

Full description

Bibliographic Details
Main Authors:	O. Capdevila, F. Mitjavila, G. Espinosa, L. Caminal-Montero, A. Marín-Ballvè, R. González León, A. Castro, J. Canora, B. Pinilla, E. Fonseca, G. Ruiz-Irastorza
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Medicina
Subjects:	systemic lupus erythematosus belimumab rituximab
Online Access:	https://www.mdpi.com/1648-9144/59/8/1362

Similar Items

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

Treatment of thrombotic microangiopathy associated with systemic lupus erythematosus with low-dose rituximab as an induction agent and belimumab as a maintenance agent
by: Zhenle Yang, et al.
Published: (2025-02-01)

Pharmacoeconomic analysis of rituximab and belimumab therapy in patients with systemic lupus erythematosus
by: D. A. Gerasimova, et al.
Published: (2024-10-01)

Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
by: Sabih Ul Hassan, et al.
Published: (2020-08-01)

Long-term results of therapy with sequential use of rituximab and belimumab in patients with systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2023-10-01)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
by: Mieke van Schaik, et al.
Published: (2022-11-01)

Safety of belimumab in association with denosumab in a patient affected by Lupus Erythematosus: a case report
by: Marco Scarati, et al.
Published: (2017-04-01)

Lupus nephritis - case report of an uncommon succession of therapies
by: Andreea Rovinaru, et al.
Published: (2023-12-01)

PROSPECTS FOR PHARMACOTHERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. L. Nasonov, et al.
Published: (2014-06-01)

Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China
by: Zishan Lin, et al.
Published: (2024-09-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
by: Han Zhang, et al.
Published: (2023-12-01)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
by: Patrick Muller, et al.
Published: (2020-07-01)

RESULTS OF AN OBSERVATIONAL PROSPECTIVE STUDY OF THE EFFICACY AND SAFETY OF BELIMUMAB (BENLYSTA®) IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE
by: E. A. Aseeva, et al.
Published: (2016-03-01)

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2019-03-01)

THE EFFICIENCY OF BIOLOGICAL THERAPY AND THE FEATURES OF HUMORAL IMMUNITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2018-07-01)

Experience of long-term belimumab use in patients with systemic lupus erythematosus (a case report)
by: Natalia Gennadyevna Klyukvina
Published: (2013-06-01)

Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain
by: Silvia Díaz-Cerezo, et al.
Published: (2015-02-01)

THE TIME COURSE OF CHANGES IN B LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS DURING THERAPY WITH BIOLOGICAL AGENTS
by: A. A. Mesnyankina, et al.
Published: (2017-07-01)

Belimumab in the treatment of systemic lupus erythematosus with juvenile onset: Results of a single-center retrospective study
by: Maria I. Kaleda, et al.
Published: (2024-09-01)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
by: Mark E. McClure, et al.
Published: (2023-03-01)

Belimumab in early systemic lupus erythematosus: A propensity score matching analysis
by: Chaofan Lu, et al.
Published: (2024-08-01)

An update on the management of refractory cutaneous lupus erythematosus
by: Alice Verdelli, et al.
Published: (2022-09-01)

Long-term belimumab therapy in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2024-08-01)

Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus
by: Chisato Yoshijima, et al.
Published: (2024-08-01)

Successful management of belimumab after obinutuzumab in a patient with systemic lupus erythematosus: a case report with an 18-month follow-up
by: Xiuxiu Pu, et al.
Published: (2024-10-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label Study
by: Jing Zhang, et al.
Published: (2020-01-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

Belimumab in childhood systemic lupus erythematosus: A review of available data
by: Feng Chen, et al.
Published: (2022-07-01)

DUAL THERAPY WITH BIOLOGICALS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: A. A. Mesnyankina, et al.
Published: (2016-07-01)

Prospects for anti-BLyS treatment of systemic lupus erythematosus
by: S. K. Solovyov, et al.
Published: (2019-06-01)

Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review
by: Chisato Yoshijima, BSPharm, et al.
Published: (2024-01-01)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019-04-01)

Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
by: A. G. Tolkushin, et al.
Published: (2018-11-01)

Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
by: Chunye Wu, et al.
Published: (2022-11-01)

Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01)

Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study
by: Bernard Rubin, et al.
Published: (2024-06-01)